Clindamiac (Clindamycin Phosphate)
Clindamycin Phosphate 1.188g
Solution · Prescription medication
Jeongwoo Pharmaceutical Co., Ltd.
MFDS item code 202101699 · Notified 2021.02.19
Treatment of acne vulgaris by inhibiting Propionibacterium acnes
This medication is primarily used to treat acne vulgaris, which is caused by the bacterium Propionibacterium acnes.
Apply a thin layer to the affected area twice a day. Clean the affected area before application.
This medication is an antibiotic containing clindamycin, and individuals with certain diseases or a history of allergies should avoid its use. Patients allergic to clindamycin or lincomycin, or those with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis should not use this medication. Additionally, it is safer for pregnant women or women who may become pregnant, nursing mothers, and children under 12 years of age to avoid this medication. This medication contains propylene glycol, and individuals with allergic reactions or hypersensitivity to this ingredient should use it cautiously. Patients with atopic conditions should consult a physician or pharmacist before using this medication. When using this medication, skin reactions such as dryness, irritation, itching, rash, or gastrointestinal symptoms such as abdominal pain, digestive disturbances, and diarrhea may occur, so if any of these symptoms develop, use should be stopped immediately and a healthcare professional consulted. Particularly, this medication can cause severe gastrointestinal disorders such as severe diarrhea or bloody stools; if such symptoms occur, administration should be ceased immediately and medical diagnosis obtained. It is important to use this medication only for the necessary minimum period to prevent antibiotic resistance and avoid overuse. Moreover, although this medication is a topical preparation applied to the skin, some may be absorbed into the body, leading to systemic side effects. Animal experiments have shown no major issues during pregnancy; however, due to the lack of established safety in humans, it is recommended to avoid use during pregnancy. Nursing mothers should also cease breastfeeding, as there is a possibility of this medication being secreted in breast milk. For children under 12 years old, it is advisable to avoid use due to uncertainty regarding safety and efficacy. Excessive application may affect the whole body, so appropriate amounts should be adhered to. Finally, this medication should be stored out of reach of children, tightly sealed in its original container, and transferring to other containers can lead to quality degradation or misuse.
Diarrhea, bloody diarrhea, colitis including pseudomembranous colitis, antibiotic-associated colitis
Skin dryness, contact dermatitis, skin irritation (macules, peeling, burning sensation, itching, dryness, redness, etc.), seborrhea (greasy skin), abdominal pain, digestive disturbances, Gram-negative folliculitis, hypersensitivity reactions, eye discomfort
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent the ingress of air and moisture, and it is safest to store it at room temperature between 1 and 30 degrees Celsius. Therefore, avoid extremely hot or cold places, and it is advisable to keep it in a cool place away from direct sunlight.
Colorless topical solution with an alcohol smell in a plastic container
30 milliliters per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Clindamycin Phosphate 1.188g
Solution · Prescription medication
Jeongwoo Pharmaceutical Co., Ltd.
Clindamycin Phosphate 300mg
Injections · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Clindamycin Phosphate 600mg
Injections · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Clindamycin Phosphate 1.188g
Solution · Prescription medication
HighPharm Life Science Co., Ltd.
Clindamycin Phosphate
Prescription medication
Korea Pfizer Pharmaceutical Co., Ltd.
Clindamycin Phosphate
Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Clindamycin Phosphate
Prescription medication
HyunDae Pharmaceutical Co., Ltd.
Clindamycin Phosphate 1.188g
Solution · Prescription medication
Medica Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.